Kenvue Inc. $KVUE Stock Holdings Lifted by Alberta Investment Management Corp

Alberta Investment Management Corp increased its position in shares of Kenvue Inc. (NYSE:KVUE) by 23.8% during the third quarter, Holdings Channel reports. The fund owned 1,106,716 shares of the company’s stock after acquiring an additional 213,000 shares during the quarter. Alberta Investment Management Corp’s holdings in Kenvue were worth $17,962,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in the company. Essex Financial Services Inc. grew its position in Kenvue by 46.7% during the third quarter. Essex Financial Services Inc. now owns 14,246 shares of the company’s stock valued at $231,000 after purchasing an additional 4,534 shares in the last quarter. Waycross Partners LLC acquired a new stake in shares of Kenvue during the 3rd quarter valued at $3,246,000. Martin & Co. Inc. TN grew its holdings in shares of Kenvue by 1.0% during the 3rd quarter. Martin & Co. Inc. TN now owns 170,640 shares of the company’s stock valued at $2,769,000 after acquiring an additional 1,612 shares in the last quarter. NEOS Investment Management LLC grew its holdings in shares of Kenvue by 49.3% during the 3rd quarter. NEOS Investment Management LLC now owns 241,756 shares of the company’s stock valued at $3,924,000 after acquiring an additional 79,835 shares in the last quarter. Finally, NJ State Employees Deferred Compensation Plan increased its stake in shares of Kenvue by 180.4% in the third quarter. NJ State Employees Deferred Compensation Plan now owns 29,300 shares of the company’s stock worth $476,000 after acquiring an additional 18,850 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Analysts Set New Price Targets

KVUE has been the subject of a number of research reports. Evercore set a $18.00 price objective on Kenvue in a research report on Tuesday, October 28th. Barclays raised their price target on Kenvue from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research note on Monday, November 10th. Deutsche Bank Aktiengesellschaft set a $18.00 price target on Kenvue in a research note on Friday, October 24th. Canaccord Genuity Group increased their price objective on Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a report on Wednesday. Finally, Johnson Rice reaffirmed a “neutral” rating on shares of Kenvue in a research report on Tuesday, October 28th. Four analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the stock. According to data from MarketBeat, Kenvue has a consensus rating of “Hold” and an average target price of $20.08.

Insider Transactions at Kenvue

In other news, Director Jeffrey C. Smith bought 3,200,000 shares of the company’s stock in a transaction that occurred on Friday, December 12th. The shares were purchased at an average price of $17.37 per share, for a total transaction of $55,584,000.00. Following the acquisition, the director directly owned 27,307,632 shares of the company’s stock, valued at $474,333,567.84. The trade was a 13.27% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 1.68% of the company’s stock.

Kenvue Stock Performance

Shares of NYSE KVUE opened at $18.87 on Thursday. The business’s 50-day simple moving average is $17.48 and its 200-day simple moving average is $17.66. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 0.98. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $25.17. The firm has a market cap of $36.15 billion, a price-to-earnings ratio of 24.51 and a beta of 0.59.

Kenvue (NYSE:KVUE) last posted its earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.22 by $0.05. Kenvue had a return on equity of 19.86% and a net margin of 9.72%.The firm had revenue of $3.78 billion during the quarter, compared to analyst estimates of $3.68 billion. During the same period in the previous year, the company earned $0.26 EPS. The company’s revenue for the quarter was up 3.2% on a year-over-year basis. As a group, equities research analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th will be issued a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a dividend yield of 4.4%. The ex-dividend date of this dividend is Wednesday, February 11th. Kenvue’s dividend payout ratio is currently 110.67%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.